drugset / Trial / NCT01389518

Efficacy and Safety of Paracetamol, Chlorpheniramine and Phenylephrine in the Treatment of Common Cold and Flu Syndrome

NCT01389518

Phase 3 Completed 146 enrolled Hospital de Clinicas de Porto Alegre
RandomizedFactorialQuadruple-blindTreatment

Summary

The aim of this study is to evaluate the efficacy and safety of a fixed combination of paracetamol, phenylephrine and chlorpheniramine in symptomatic treatment of common cold and flu-like illness in adults in a randomized, double-blind, controlled trial. The investigators included 146 healthy study subjects aged between 18 and 60 years who presented flu or common cold moderate to severe onset of less than 3 days (72 hours). After clinical and laboratory evaluation were randomized to receive active drug or placebo, five capsules a day, every 4 hours for 48-72h.The outcomes to assess the effectiveness involve the measurement of symptom scores, overall duration of symptoms, return to usual activities, use of rescue medication, improvement of the fever.

Timeline

Start
2009-05
Primary completion
2009-07
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule
Comparator Chlorpheniramine Unknown
Comparator Phenylephrine Small molecule

Indications